$3.860
+0.135 (+3.49%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
RCKT 相似图表分析预测
Alphio's RCKT stock price prediction model matches the current Rocket Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.86 (+0.12%). The 1-week path is $3.77 (-2.32%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Rocket Pharmaceuticals Inc 股票吗？
Rocket Pharmaceuticals appears to be a good buy right now due to its recent positive momentum, with a 20-day price change of +24.12% and a significant cash position of over $320 million after a recent sale, which enhances its financial stability. The RSI is at 69.022, indicating strong momentum, although it is approaching overbought territory. The main risk is the negative earnings per share of -0.15 reported in the last earnings, which may affect investor confidence.
RCKT 股价于 Wednesday 收于 $3.86，此前上涨 +3.49%
Rocket Pharmaceuticals Inc (RCKT) last closed at $3.86, gaining +3.49%. These facts feed the 1-day and 1-week RCKT price prediction above.
分析师一致预期
Rocket Pharmaceuticals Inc（RCKT）：买入 1、持有 0、卖出 0。展望：Strong Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
预测驱动因素
Rocket Pharmaceuticals Inc（RCKT）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
相似图表形态
近期走势与 RCKT 最接近的股票，按相似度排序。
RCKT 季节性分析
Historically the probability of a positive September return for RCKT is 4.65%. March offers the highest probability of a positive month at 34.92%, while October is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。